BAYER AG
Company Snapshot
Company Overview
Bayer AG is a life science company with core competencies in healthcare and agriculture. It manages its business through three divisions: pharmaceuticals, consumer health, and crop science.
Bayer’s pharmaceutical division focuses on prescription products (name few Kogenate, Betaseron. Cipro (Ciprofloxacin), Adempas (Riociguat), and Xofigo (Radium-223 dichloride) ), especially cardiology; women’s health; and specialty therapeutics in oncology, hematology and ophthalmology. Cell and gene therapy is one of the company’s focus areas. It has established an independent strategic unit for cell and gene therapy.
Consumer Health is a leading supplier of OTC medicines, nutritional supplements, medicated skincare products, and other self-care solutions for pain, cardiovascular risk prevention, dermatology, digestive health, allergy, and cough and cold.
Financial Highlights (FY 2024)
This information is available for BCC Research members only.
Company's Business Segments
- Crop Science : Crop protection, seeds and traits, digital farming, fruits & vegetables, environmental science.
- Pharmaceuticals : Treatments and therapies, Cell and gene therapies.
- Consumer Health : Nutritional supplements, Allergy, Cough & cold, Dermatology, Pain and cardiovascular risk prevention, Digestive health.
- All other Segments : The revenue sources here mainly comprise income from marketing rights and from catering services.
- Enabling Functions and Consolidation : Telates to Group-wide competence centers and business support services as well as “Leaps by Bayer"
Applications/End User Industries
- Cardiology
- Hematology
- Oncology
- Chronic Kidney Disease
- Eye Condition
- Healthy Aging
- Hormonal and Reprodcutive Health
- Digital Farming System
- Seeds
- Traits
- Crop Protection
- Climate Change
- Environmental Science
- Personal Health
- Pharmaceuticals
- Healthcare
